Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model

We have previously shown that immunization with tumor antigen-loaded dendritic cells (DCs) and the immunomodulating drug, lenalidomide, synergistically potentiates the enhancing antitumor immunity in a myeloma mouse model. In this study, we investigated the immunogenicity of DCs combined with pomali...

Descripción completa

Detalles Bibliográficos
Autores principales: Vo, Manh-Cuong, Yang, Seoyun, Jung, Sung-Hoon, Chu, Tan-Huy, Lee, Hyun-Ju, Lakshmi, Thangaraj Jaya, Park, Hye-Seong, Kim, Hyeoung-Joon, Lee, Je-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085413/
https://www.ncbi.nlm.nih.gov/pubmed/30123221
http://dx.doi.org/10.3389/fimmu.2018.01798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085413/
https://www.ncbi.nlm.nih.gov/pubmed/30123221
http://dx.doi.org/10.3389/fimmu.2018.01798

Ejemplares similares